Caxton Associates »

C4 Therapeutics shares owned by Caxton Associates

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Caxton Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $172k 21k 8.17
2023-06-30 $74k 27k 2.75
2023-03-31 $122k 39k 3.14